Jackson Grant Investment Advisers Inc. raised its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 30,647 shares of the company’s stock after buying an additional 172 shares during the quarter. […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Duncker Streett & Co. Inc. raised its position in Apple Inc. (NASDAQ:AAPL – Free Report) by 3.7% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 85,574 shares of the iPhone maker’s stock after acquiring an additional 3,019 shares during the period. Apple makes up 3.7% of Duncker […]
AbbVie Inc. (NYSE:ABBV – Free Report) – Analysts at Zacks Research decreased their Q3 2023 earnings per share estimates for shares of AbbVie in a research report issued on Thursday, October 19th. Zacks Research analyst S. Ganoria now forecasts that the company will earn $2.83 per share for the quarter, down from their prior forecast […]
Klingenstein Fields & Co. LP lowered its stake in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 0.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 15,073 shares of the company’s stock after selling 85 shares during the quarter. Klingenstein […]